About Ipsen

Company Description

Improving lives and health outcomes.

Ipsen’s vision is to be a leading global mid-size biopharmaceutical company, with a focus on transformative medicines in three key therapeutic areas: oncology, rare disease and neuroscience.

At Ipsen, we’re dedicated to improving people’s lives and health outcomes. Our 5,700 employees around the world are committed to tackling areas of high unmet medical need to improve the quality of life of patients and caregivers.

Year founded

1929

Served area

Worldwide

Headcount

5,700

Headquarters

65 Quai Georges Gorse, 92100 Boulogne-Billancourt – France

Shareholder information

Shares outstanding

83,814,526

IPO

Dec. 6, 2005

Stock exchange(s)

Euronext Paris

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.